NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q3 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,541 | +587.9% | 14,229 | +482.0% | 0.17% | +625.0% |
| Q1 2024 | $224 | -70.8% | 2,445 | -80.1% | 0.02% | -70.4% |
| Q4 2023 | $768 | +74.9% | 12,262 | +23.5% | 0.08% | +84.1% |
| Q3 2023 | $439 | -99.9% | 9,930 | -23.0% | 0.04% | -21.4% |
| Q3 2022 | $565,000 | -80.2% | 12,900 | -48.6% | 0.06% | -80.5% |
| Q2 2021 | $2,852,000 | +764.2% | 25,120 | +657.1% | 0.29% | +441.5% |
| Q4 2020 | $330,000 | -67.8% | 3,318 | -76.6% | 0.05% | -67.9% |
| Q3 2020 | $1,026,000 | +27.5% | 14,207 | -12.0% | 0.16% | +36.4% |
| Q2 2020 | $805,000 | -21.3% | 16,138 | -52.9% | 0.12% | -39.5% |
| Q1 2020 | $1,023,000 | +106.7% | 34,259 | +133.0% | 0.20% | +153.2% |
| Q4 2019 | $495,000 | +78.7% | 14,701 | +46.5% | 0.08% | +68.1% |
| Q2 2019 | $277,000 | -14.0% | 10,035 | -25.3% | 0.05% | +4.4% |
| Q3 2018 | $322,000 | +86.1% | 13,430 | -6.1% | 0.04% | -4.3% |
| Q2 2016 | $173,000 | -44.2% | 14,309 | -49.9% | 0.05% | -55.2% |
| Q3 2015 | $310,000 | – | 28,543 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 503,094 | $54,480,049 | 52.98% |
| Kynam Capital Management, LP | 2,014,408 | $218,140,242 | 16.83% |
| Eagle Health Investments LP | 474,114 | $51,341,805 | 9.00% |
| Sofinnova Investments, Inc. | 1,550,280 | $167,879,821 | 8.72% |
| Eversept Partners, LP | 1,173,494 | $127,077,665 | 8.70% |
| Lagoda Investment Management, L.P. | 130,195 | $14,098,817 | 8.11% |
| Duquesne Family Office | 1,974,880 | $213,860 | 7.33% |
| Tri Locum Partners LP | 230,585 | $24,970,050 | 6.31% |
| PERKINS CAPITAL MANAGEMENT INC | 57,550 | $6,232 | 5.87% |
| PURA VIDA INVESTMENTS, LLC | 67,500 | $7,309,575 | 4.63% |